Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-25

Clinical Trial Update: A Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial update for PG-011 nasal spray in adults with seasonal allergic rhinitis; the study is currently active but not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PG-011

Snippet

Sponsor: Prime Gene Therapeutics Co., Ltd. | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING